ANAB: AnaptysBio, Inc.
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
2021-04-22 16:12:09
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
Pernyataan Penyangkalan
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Pernyataan Penyangkalan
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.